Overview Dividends

(SWBI) Smith & Wesson Brands - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8317541063

Firearms, Handguns, Revolvers, Pistols, Long Guns

Leisure Products
Market Cap in USD: 482m

IPO / Inception: 1998-11-09
Return 12m vs S&P 500: -8.59%

EPS (Earnings per Share)

EPS CAGR: -53.21%
EPS Trend: -67.3%

Last SUE: 0.40
Qual. Beats: 0

Revenue

Rev. CAGR: -9.02%
Rev. Trend: -33.0%

Last SUE: 0.13
Qual. Beats: 0

Dividends

Dividend Yield	5.01%
Yield on Cost 5y	3.54%
Yield CAGR 5y	50.28%
Payout Consistency	100.0%
Payout Ratio	2.9%

Risk via 5d forecast
Volatility	46.0%
Value at Risk 5%th	50.5%
Relative Tail Risk	-33.27%

Reward TTM
Sharpe Ratio	0.22
Alpha	-9.29
CAGR/Max DD	0.20

Character TTM
Hurst Exponent	0.521
Beta	0.606
Beta Downside	0.386

Drawdowns 3y
Max DD	54.24%
Mean DD	21.18%
Median DD	13.80%

Description: SWBI Smith & Wesson Brands October 24, 2025

Smith & Wesson Brands, Inc. (NASDAQ: SWBI) designs, manufactures, and sells a full spectrum of firearms-including handguns, modern sporting rifles, and lever-action rifles-plus accessories such as suppressors and handcuffs. The firm also offers contract-manufacturing services (forging, heat treating, rapid prototyping, etc.) to third-party customers, expanding its revenue beyond end-user sales.

As of the most recent quarter (Q2 2024), SWBI reported revenue of $258 million, a 12 % YoY increase driven by heightened civilian demand and a 9 % rise in law-enforcement contracts. The company’s gross margin improved to 38 % from 34 % a year earlier, reflecting cost efficiencies in its in-house machining and injection-molding operations. A key sector driver remains the U.S. civilian firearms market, which the NSSF estimates will exceed $13 billion in 2025, while ongoing regulatory uncertainty (e.g., potential federal restrictions on “assault-style” weapons) adds downside risk.

Investors should monitor the balance between civilian sales growth-sensitive to political cycles and consumer confidence-and the stability of law-enforcement and military contracts, which provide a more predictable cash flow. For a deeper quantitative view, consider exploring ValueRay’s detailed valuation model for SWBI.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (9.90m TTM) > 0 and > 6% of Revenue (6% = 28.0m TTM)

FCFTA 0.07 (>2.0%) and ΔFCFTA 5.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 46.02% (prev 44.47%; Δ 1.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 50.1m > Net Income 9.90m (YES >=105%, WARN >=100%)

Net Debt (101.1m) to EBITDA (44.0m) ratio: 2.30 <= 3.0 (WARN <= 3.5)

Current Ratio 4.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (44.7m) change vs 12m ago -0.44% (target <= -2.0% for YES)

Gross Margin 25.93% (prev 30.21%; Δ -4.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 82.11% (prev 87.61%; Δ -5.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.14 (EBITDA TTM 44.0m / Interest Expense TTM 5.06m) >= 6 (WARN >= 3)

Altman Z'' 8.78

(A) 0.39 = (Total Current Assets 268.5m - Total Current Liabilities 53.9m) / Total Assets 548.6m

(B) 0.95 = Retained Earnings (Balance) 519.5m / Total Assets 548.6m

warn (B) unusual magnitude: 0.95 — check mapping/units

(D) 2.80 = Book Value of Equity 519.5m / Total Liabilities 185.4m

Total Rating: 8.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 45.22

1. Piotroski 4.50pt

2. FCF Yield 6.31%

3. FCF Margin 7.82%

4. Debt/Equity 0.34

5. Debt/Ebitda 2.30

6. ROIC - WACC (= -4.51)%

7. RoE 2.71%

8. Rev. Trend -33.02%

9. EPS Trend -67.33%

What is the price of SWBI shares?

As of December 21, 2025, the stock is trading at USD 10.37 with a total of 834,759 shares traded.
Over the past week, the price has changed by -3.06%, over one month by +28.66%, over three months by +11.93% and over the past year by +7.44%.

Is SWBI a buy, sell or hold?

Smith & Wesson Brands has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy SWBI.

Strong Buy: 2
Buy: 0
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SWBI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	13.5	30.2%
Analysts Target Price	13.5	30.2%
ValueRay Target Price	10.6	1.7%

SWBI Fundamental Data Overview December 14, 2025

Market Cap USD = 481.9m (481.9m USD * 1.0 USD.USD)
P/E Trailing = 51.5714
P/S = 1.0332
P/B = 1.3267
Beta = 1.12
Revenue TTM = 466.4m USD
EBIT TTM = 15.9m USD
EBITDA TTM = 44.0m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.78m USD (from shortTermDebt, last quarter)
Debt = 123.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 101.1m USD (from netDebt column, last quarter)
Enterprise Value = 578.1m USD (481.9m + Debt 123.6m - CCE 27.3m)
Interest Coverage Ratio = 3.14 (Ebit TTM 15.9m / Interest Expense TTM 5.06m)
FCF Yield = 6.31% (FCF TTM 36.5m / Enterprise Value 578.1m)
FCF Margin = 7.82% (FCF TTM 36.5m / Revenue TTM 466.4m)
Net Margin = 2.12% (Net Income TTM 9.90m / Revenue TTM 466.4m)
Gross Margin = 25.93% ((Revenue TTM 466.4m - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 25.95%)
Tobins Q-Ratio = 1.05 (Enterprise Value 578.1m / Total Assets 548.6m)
Interest Expense / Debt = 1.12% (Interest Expense 1.39m / Debt 123.6m)
Taxrate = 36.25% (1.09m / 3.01m)
NOPAT = 10.1m (EBIT 15.9m * (1 - 36.25%))
Current Ratio = 4.98 (Total Current Assets 268.5m / Total Current Liabilities 53.9m)
Debt / Equity = 0.34 (Debt 123.6m / totalStockholderEquity, last quarter 363.2m)
Debt / EBITDA = 2.30 (Net Debt 101.1m / EBITDA 44.0m)
Debt / FCF = 2.77 (Net Debt 101.1m / FCF TTM 36.5m)
Total Stockholder Equity = 366.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.81% (Net Income 9.90m / Total Assets 548.6m)
RoE = 2.71% (Net Income TTM 9.90m / Total Stockholder Equity 366.0m)
RoCE = 3.49% (EBIT 15.9m / Capital Employed (Equity 366.0m + L.T.Debt 89.0m))
RoIC = 2.21% (NOPAT 10.1m / Invested Capital 458.8m)
WACC = 6.71% (E(481.9m)/V(605.4m) * Re(8.25%) + D(123.6m)/V(605.4m) * Rd(1.12%) * (1-Tc(0.36)))
Discount Rate = 8.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.09%
[DCF Debug] Terminal Value 69.54% ; FCFE base≈24.7m ; Y1≈16.2m ; Y5≈7.40m
Fair Price DCF = 3.16 (DCF Value 140.5m / Shares Outstanding 44.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -67.33 | EPS CAGR: -53.21% | SUE: 0.40 | # QB: 0
Revenue Correlation: -33.02 | Revenue CAGR: -9.02% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.05 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-04-30): EPS=0.25 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=-24.2% | Growth Revenue=+0.6%
EPS next Year (2027-04-30): EPS=0.28 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.2%

Additional Sources for SWBI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle